Alpha DNA Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-28,306
| Closed | -$819K | – | 242 |
|
|
2024
Q3 | $819K | Sell |
28,306
-4,697
| -14% | -$136K | 0.31% | 70 |
|
|
2024
Q2 | $923K | Sell |
33,003
-1,622
| -5% | -$45.4K | 0.36% | 57 |
|
|
2024
Q1 | $961K | Buy |
34,625
+5,746
| +20% | +$159K | 0.35% | 52 |
|
|
2023
Q4 | $831K | Sell |
28,879
-1,435
| -5% | -$41.3K | 0.32% | 56 |
|
|
2023
Q3 | $1.01M | Sell |
30,314
-21,908
| -42% | -$727K | 0.41% | 46 |
|
|
2023
Q2 | $1.92M | Buy |
52,222
+8,863
| +20% | +$325K | 0.64% | 27 |
|
|
2023
Q1 | $1.77M | Buy |
43,359
+22,748
| +110% | +$928K | 0.52% | 23 |
|
|
2022
Q4 | $1.06M | Sell |
20,611
-29,972
| -59% | -$1.54M | 0.37% | 101 |
|
|
2022
Q3 | $2.21M | Buy |
+50,583
| New | +$2.21M | 1.84% | 5 |
|
|
2021
Q2 | – | Sell |
-1,090
| Closed | -$39K | – | 485 |
|
|
2021
Q1 | $39K | Buy |
1,090
+374
| +52% | +$13.4K | 0.04% | 205 |
|
|
2020
Q4 | $26K | Buy |
+716
| New | +$26K | 0.03% | 237 |
|